Page 133 - FINAL PROGRAMME 2017
P. 133

TUESDAY, 4 JULY 2017
SELECTED ORAL COMMUNICATIONS
17:00 - 18:00 Plenary 2
Session 53: Fertility preservation
Chairman: J. Stukenborg (Sweden) Chairman: F. Urner (Switzerland)
17:00 O-195
Spontaneous activation of human primordial follicles and subsequent follicular development to the antral stage during matrix-free three-dimensional culture
J. Xu1,2, M. Lawson1, K. Kester3, A. Jackman3, F. Xu2
1Oregon National Primate Research Center- Oregon Health & Science University, Division of Reproductive & Developmental Sciences, Beaverton, U.S.A.
2School of Medicine- Oregon Health & Science University, Department of Obstetrics and Gynecology, Portland, U.S.A.
3School of Medicine- Oregon Health & Science University, Department of Pathology, Portland, U.S.A.
Multicolor  ow cytometry: a promising tool for ovarian tissue quali cation and minimal residual disease detection in human ovarian cortex
T. Zver1,2, E. Mouloungui1,2,3, A. Berdin4, C. Amiot1,2,3,5, C. Roux1,2,3,5
1Centre Hospitalier Régional Universitaire, Biologie et Médecine de la Reproduction-Cryobiologie - CECOS, Besançon, France
2INSERM, UMR 1098, Besançon, France
3Université de Bourgogne - Franche-Comté, UFR de Sciences Médicales et Pharmaceutiques, Besançon, France
4Centre Hospitalier Régional Universitaire, Service de Gynécologie - Obstétrique, Besançon, France 5Centre Hospitalier Régional Universitaire, CIC 1431, Besançon, France
Glycogen synthase kinase 3 (GSK3) inhibition decreases cisplatin-induced oocyte death in vitro
V. Rossi1, A. Stefandottir2, F. Lopes2, R. Anderson3, M. De Felici1, N. Spears2, F.G. Klinger1 1University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy 2University of Edinburgh, Centre for Integrative Physiology, Edinburgh, United Kingdom 3University of Edinburgh, MRC Centre for Reproductive Health, Edinburgh, United Kingdom
Effect of inhibitor and activators of PI3K/Akt/mTOR pathway on human primordial follicles activation and growth in vitro: to slow down for better quality?
J. Grosbois1, I. Demeestere2
1Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Bruxelles, Belgium
2Research Laboratory on Human Reproduction- Fertility Clinic- Gynecology and Obstetrics Department- Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium
17:15 O-196
17:30 O-197
17:45 O-198
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 133
SCIENTIFIC PROGRAMME TUESDAY, 4 JULY


































































































   131   132   133   134   135